The AP-1 repressor protein, JDP2, potentiates hepatocellular carcinoma in mice

Molecular Cancer

Volumn 9, Issue , 2010, Pages

  Bitton Worms, Keren ^a   Pikarsky, Eli ^b   Aronheim, Ami ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BETA GALACTOSIDASE; C JUN DIMERIZATION PROTEIN 2; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; DIETHYLNITROSAMINE; JUNDP2 PROTEIN, MOUSE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER STAGING; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; LIVER CELL; LIVER CELL CARCINOMA; LIVER INJURY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR VOLUME; ANIMAL; ANTIBODY SPECIFICITY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; LIVER; LIVER TUMOR; METABOLISM; PATHOLOGY; SURVIVAL; TRANSGENIC MOUSE;

MUS; MUS MUSCULUS;

ANIMALS; CARCINOMA, HEPATOCELLULAR; DIETHYLNITROSAMINE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; LIVER; LIVER NEOPLASMS; MICE; MICE, TRANSGENIC; ORGAN SPECIFICITY; REPRESSOR PROTEINS; SURVIVAL ANALYSIS; TRANSCRIPTION FACTOR AP-1;

EID: 77950388106     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-9-54     Document Type: Article

References (38)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001, 94:153-156. 10.1002/ijc.1440, 11668491.
2. Block TM, Mehta AS, Fimmel CJ, Jordan R. Molecular viral oncology of hepatocellular carcinoma. Oncogene 2003, 22:5093-5107. 10.1038/sj.onc.1206557, 12910247.
3. Nakamoto Y, Kaneko S. Mechanisms of viral hepatitis induced liver injury. Curr Mol Med 2003, 3:537-544. 10.2174/1566524033479591, 14527085.
4. Brechot C. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology 2004, 127:S56-61. 10.1053/j.gastro.2004.09.016, 15508104.
5. Wu X, Pandolfi PP. Mouse models for multistep tumorigenesis. Trends Cell Biol 2001, 11:S2-S9.
6. Kato M, Popp JA, Conolly RB, Cattley RC. Relationship between hepatocyte necrosis, proliferation, and initiation induced by diethylnitrosamine in the male F344 rat. Fundam Appl Toxicol 1993, 20:155-162. 10.1006/faat.1993.1021, 8449386.
7. Lee JS, Chu IS, Mikaelyan A, Calvisi DF, Heo J, Reddy JK, Thorgeirsson SS. Application of comparative functional genomics to identify best-fit mouse models to study human cancer. Nat Genet 2004, 36:1306-1311. 10.1038/ng1481, 15565109.
8. Maeda S, Kamata H, Luo JL, Leffert H, Karin M. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 2005, 121:977-990. 10.1016/j.cell.2005.04.014, 15989949.
9. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E, Ben-Neriah Y. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004, 431:461-466. 10.1038/nature02924, 15329734.
10. Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005, 5:749-759. 10.1038/nri1703, 16175180.
11. Wagner EF. AP-1--Introductory remarks. Oncogene 2001, 20:2334-2335. 10.1038/sj.onc.1204416, 11402330.
12. Maeda S, Karin M. Oncogene at last - c-Jun promotes liver cancer in mice. Cancer Cells 2003, 3:102-104.
13. Jochum W, Passegue E, Wagner EF. AP-1 in mouse development and tumorigenesis. Oncogene 2001, 20:2401-2412. 10.1038/sj.onc.1204389, 11402336.
14. Smeal T, Benetruy B, Mercola D, Birrer M, Karin M. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature 1991, 354:494-496. 10.1038/354494a0, 1749429.
15. Johnson RS, Van Lingen B, Papaioannou VE, Spiegelman BM. A null mutation at the c-Jun locus causes embryonic lethality and retarded cell growth in culture. Genes and Dev 1993, 7:1309-1317. 10.1101/gad.7.7b.1309, 8330736.
16. Eferl R, Ricci R, Kenner L, Zenz R, Davisd J-P, Rath M, Wagner EF. Liver tumor development: c-Jun antagonizes the proapoptotic activity of p53. Cell 2003, 112:181-192. 10.1016/S0092-8674(03)00042-4, 12553907.
17. Aronheim A, Zandi E, Hennemann H, Elledge S, Karin M. Isolation of an AP-1 repressor by a novel method for detecting protein-protein interactions. Mol Cell Biol 1997, 17:3094-3102. 232162, 9154808.
18. Jin C, Ugai H, Song J, Murata T, Nili F, Sun K, Horikoshi M, Yokoyama KK. Identification of mouse Jun dimerization protein 2 as a novel repressor of ATF-2. FEBS Lett 2001, 489:34-41. 10.1016/S0014-5793(00)02387-5, 11231009.
19. Jin C, Li H, Murata T, Sun K, Horikoshi M, Chiu R, Yokoyama KK. JDP2, a repressor of AP-1, recruits a histone deacetylase 3 complex to inhibit the retinoic acid-induced differentiation of F9 cells. Mol Cell Biol 2002, 22:4815-4826. 10.1128/MCB.22.13.4815-4826.2002, 133911, 12052888.
20. Ostrovsky O, Bengal E, Aronheim A. Induction of terminal differentiation by the c-Jun dimerization protein JDP2 in C2 myoblasts and rhabdomyosarcoma cells. J Biol Chem 2002, 277:40043-40054. 10.1074/jbc.M205494200, 12171923.
21. Kawaida R, Ohtsuka T, Okutsu J, Takahashi T, Kadono Y, Oda H, Hikita A, Nakamura K, Tanaka S, Furukawa H. Jun dimerization protein 2 (JDP2), a member of the AP-1 family of transcription factor, mediates osteoclast differentiation induced by RANKL. J Exp Med 2003, 197:1029-1035. 10.1084/jem.20021321, 2193879, 12707301.
22. Piu F, Aronheim A, Katz S, Karin M. AP-1 repressor protein JDP-2: inhibition of UV-mediated apoptosis through p53 down-regulation. Mol Cell Biol 2001, 21:3012-3024. 10.1128/MCB.21.9.3012-3024.2001, 86930, 11287607.
23. Heinrich R, Livne E, Ben-Izhak O, Aronheim A. The c-Jun Dimerization Protein 2 Inhibits Cell Transformation and Acts as a Tumor Suppressor Gene. J Biol Chem 2004, 279:5708-5715. 10.1074/jbc.M307608200, 14627710.
24. Hwang HC, Martins CP, Bronkhorst Y, Randel E, Berns A, Fero M, Clurman BE. Identification of oncogenes collaborating with p27Kip1 loss by insertional mutagenesis and high-throughput insertion site analysis. Proc Natl Acad Sci USA 2002, 99:11293-11298. 10.1073/pnas.162356099, 123250, 12151601.
25. Rasmussen MH, Sorensen AB, Morris DW, Dutra JC, Engelhard EK, Wang CL, Schmidt J, Pedersen FS. Tumor model-specific proviral insertional mutagenesis of the Fos/Jdp2/Batf locus. Virology 2005, 337:353-364. 10.1016/j.virol.2005.04.027, 15913695.
26. Stewart M, Mackay N, Hanlon L, Blyth K, Scobie L, Cameron E, Neil JC. Insertional Mutagenesis Reveals Progression Genes and Checkpoints in MYC/Runx2 Lymphomas. Cancer Res 2007, 67:5126-5133. 10.1158/0008-5472.CAN-07-0433, 2562448, 17545590.
27. Kehat I, Heinrich R, Ben-Izhak O, Miyazaki H, Gutkind JS, Aronheim A. Inhibition of basic leucine zipper transcription is a major mediator of atrial dilatation. Cardiovasc Res 2006, 70:543-554. 10.1016/j.cardiores.2006.02.018, 16631626.
28. Kistner A, Gossen M, Zimmermann F, Jerecic J, Ullmer C, Lubbert H, Bujard H. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA 1996, 93:10933-10938. 10.1073/pnas.93.20.10933, 38261, 8855286.
29. Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, Karin M. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007, 317:121-124. 10.1126/science.1140485, 17615358.
30. Blazek E, Wasmer S, Kruse U, Aronheim A, Aoki M, Vogt PK. Partial oncogenic transformation of chicken embryo fibroblasts by Jun dimerization protein 2, a negative regulator of TRE- and CRE-dependent transcription. Oncogene 2003, 22:2151-2159. 10.1038/sj.onc.1206312, 12687017.
31. Rasmussen MH, Wang B, Wabl M, Nielsen AL, Pedersen FS. Activation of alternative Jdp2 promoters and functional protein isoforms in T-cell lymphomas by retroviral insertion mutagenesis. Nucleic Acids Res 2009, 37:4657-4671. 10.1093/nar/gkp469, 2724284, 19502497.
32. Lavon I, Goldberg I, Amit S, Landsman L, Jung S, Tsuberi BZ, Barshack I, Kopolovic J, Galun E, Bujard H, Ben-Neriah Y. High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-kappaB activation. Nat Med 2000, 6:573-577. 10.1038/75057, 10802715.
33. Young MR, Li JJ, Rincon M, Flavell RA, Sathyanarayana BK, Hunziker R, Colburn N. Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. Proc Natl Acad Sci USA 1999, 96:9827-9832. 10.1073/pnas.96.17.9827, 22295, 10449779.
34. Weidenfeld-Baranboim K, Bitton-Worms K, Aronheim A. TRE-dependent transcription activation by JDP2-CHOP10 association. Nucleic Acids Res 2008, 36:3608-3619. 10.1093/nar/gkn268, 2441799, 18463134.
35. Cherasse Y, Chaveroux C, Jousse C, Maurin AC, Carraro V, Parry L, Fafournoux P, Bruhat A. Role of the repressor JDP2 in the amino acid-regulated transcription of CHOP. FEBS Lett 2008, 582:1537-1541. 10.1016/j.febslet.2008.03.050, 18396163.
36. Weidenfeld-Baranboim K, Hasin T, Darlyuk I, Heinrich R, Elhanani O, Pan J, Yokoyama KK, Aronheim A. The ubiquitously expressed bZIP inhibitor, JDP2, suppresses the transcription of its homologue immediate early gene counterpart, ATF3. Nucleic Acids Res 2009, 37:2194-2203. 10.1093/nar/gkp083, 2673429, 19233874.
37. Yin X, Dewille JW, Hai T. A potential dichotomous role of ATF3, an adaptive-response gene, in cancer development. Oncogene 2008, 27:2118-2127. 10.1038/sj.onc.1210861, 17952119.
38. Jin C, Kato K, Chimura T, Yamasaki T, Nakade K, Murata T, Li H, Pan J, Zhao M, Sun K, et al. Regulation of histone acetylation and nucleosome assembly by transcription factor JDP2. Nat Struct Mol Biol 2006, 13:331-338. 10.1038/nsmb1063, 16518400.